- Report
- December 2024
- 80 Pages
India
From €3118EUR$3,500USD£2,713GBP
- Report
- September 2024
- 187 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- January 2025
- 70 Pages
Turkey
From €3118EUR$3,500USD£2,713GBP
- Report
- April 2024
- 180 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- December 2022
- 72 Pages
Israel
From €3118EUR$3,500USD£2,713GBP
- Report
- July 2024
- 150 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- February 2024
- 117 Pages
Global
From €4231EUR$4,750USD£3,682GBP
- Report
- April 2024
- 269 Pages
Global
From €4454EUR$5,000USD£3,876GBP
- Report
- August 2025
- 82 Pages
India
From €3118EUR$3,500USD£2,713GBP
- Report
- July 2024
- 180 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- April 2023
- 84 Pages
Europe
From €3563EUR$4,000USD£3,101GBP
- Report
- July 2024
- 150 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 150 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 150 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- June 2022
- 200 Pages
Global
From €3964EUR$4,450USD£3,449GBP

The Coronavirus Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. Diagnostics are also used to monitor the spread of the virus and to track its mutations.
The market is composed of a variety of companies, ranging from large multinationals to small startups. These companies are developing a range of tests, from rapid antigen tests to more complex molecular tests. They are also developing technologies to improve the accuracy and speed of testing, as well as to reduce the cost of testing.
Some of the major players in the Coronavirus Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Other companies in the market include BioMedomics, BioFire Diagnostics, Luminex, and Quidel. Show Less Read more